All In MedTech

Device Trial Radar · NCT01448382

Evaluation of PillCam With Blood-Sensing Feature: A Feasibility Study

Last checked: Nov 19, 2026Latest source record: Jul 31, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

39

Actual

Start

Oct 2011

Primary completion

Dec 2015

Study completion Dec 2015

Sponsor

Lead sponsor
Medtronic - MITGPublic (MDT)
Sponsor type
Industry
First posted
Oct 7, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

1. Primary Scientific Objective * Collect human clinical data to sustain the development of blood detection sensor and optimize its algorithm and parameters * Preliminary evaluation of blood detection performances in human. 2. Secondary Scientific Objective * Assessment of blood detection sensor ability to identify the anatomical location (i.e. Stomach, SB or Colon) * Evaluation of capsule transit characteristics in the GI tract * Evaluation of BBC capsule safety Study Hypothesis: It is estimated that by implementing a spectrophotometer technology in capsule and utilizing the unique characteristics of light absorption by blood in specific spectrum, the capsule will be able to automatically detect blood in the GI tract with high accuracy. As such, the system may be an add-on to video capsules to provide efficient and quick detection of blood presence (for example in OGBI patients) or as stand alone low cost capsule (without video) which could serve as a tool similar to standard FOBT.

Conditions

  • Upper GI Bleeding

Interventions

  • PillCam® capsule with Given PillCam® PlatformDevice

    capsule endoscopy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Agreement level between the blood detectors head to capsule video head in detecting subjects with blood in the GI tractTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rambam medical center

    Haifa, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.